Survey: Impact Of COVID-19 On Monoclonal Antibodies Market Industry 2020 | In-Depth Analysis

Prince

4 years ago

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024. The factors such as, increasing incidences of new cancer cases, escalating sales of biologics, growth in geriatric population, increasing pharmaceutical R&D spending, rise in prevalence of diabetes and upsurge in healthcare expenditure would drive the growth of the market. However, the market growth would be challenged by high cost involved in the development of the therapeutic monoclonal antibodies, threats associated with drugs counterfeiting and legal regulations. A few notable trends include accelerating growth rates of infectious diseases, growth in the pharmaceutical & biotechnology M&A, development of new monoclonal antibodies and emergence of stereo-specific monoclonal antibodies.

The global monoclonal antibodies market is very lucrative as there is wide scope for its application for various indications. The rising prevalence of cancer is leading to the demand for humanized monoclonal antibodies as such class of drugs can target cancer cell at rapid speed as well as reduce their multiplication. In addition, monoclonal antibodies have found application in research and development of various novel drugs as well as therapies, which is providing a great opportunity for its market growth across the world.

Get Free Sample PDF (Including Full TOC, Tables And Figures) of Market: https://www.researchmoz.us/enquiry.php?type=S&repid=2735798

The fastest growing regional market is North America due to the presence of biopharmaceutical key players and the well-established healthcare infrastructure. It is followed by Europe and Asia Pacific, which also hold considerable share in the global market, owing to the increased application of monoclonal antibodies. Further, the rising number of coronavirus cases is augmenting the need for precise therapeutic options, which is leading to the development of mono-specific and thereby would help the monoclonal antibodies market to grow considerably in coming year.

Scope of the report:

The report provides a comprehensive analysis of the global monoclonal antibodies market.
The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Novartis AG, Merck & Co., AbbVie Inc., Bristol-Myer Squibb and Amgen AG) are also presented in detail.

Key Target Audience:

Monoclonal Antibodies Manufacturers
Pharmaceuticals and Biopharmaceutical Firms
End Users (Hospitals and Research Institutes)
Investment Banks
Healthcare and Medical Consultants.
Government Bodies & Regulating Authorities

Make An Enquiry for Discount Before Buying The Report: https://www.researchmoz.us/enquiry.php?type=D&repid=2735798

Table of Content

1. Overview
1.1 Introduction
1.2 Types of Monoclonal Antibodies
1.3 Source of Monoclonal Antibodies
1.4 Advantages and Disadvantages of Monoclonal Antibodies
1.5 Monoclonal Antibodies Applications
1.6 Monoclonal Antibody Production Process

2. Impact of COVID-19
2.1 Rise in COVID-19 Death Toll
2.2 Growth in Government Spending on Healthcare
2.3 Adoption of Plasma Therapy
2.4 COVID-19 Monoclonal Antibody Candidate Drugs in Trial

3. Global Market Analysis
3.1 Global Monoclonal Antibodies Market by Value
3.2 Global Monoclonal Antibodies Market Forecast by Value
3.3 Global Monoclonal Antibodies Market Value by Source
3.3.1 Global Humanized Monoclonal Antibodies Market by Value
3.3.2 Global Humanized Monoclonal Antibodies Market Forecast by Value
3.3.3 Global Human Monoclonal Antibodies Market by Value
3.3.4 Global Human Monoclonal Antibodies Market Forecast by Value
3.3.5 Global Chimeric Monoclonal Antibodies Market by Value
3.3.6 Global Chimeric Monoclonal Antibodies Market Forecast by Value
3.3.7 Global Murine Monoclonal Antibodies Market by Value
3.3.8 Global Murine Monoclonal Antibodies Market Forecast by Value
3.4 Global Monoclonal Antibodies Market Value by Indication
3.4.1 Global Cancer Monoclonal Antibodies Market by Value
3.4.2 Global Cancer Monoclonal Antibodies Market Forecast by Value
3.4.3 Global Autoimmune Diseases Monoclonal Antibodies Market by Value
3.4.4 Global Autoimmune Diseases Monoclonal Antibodies Market Forecast by Value
3.4.5 Global Infectious Diseases Monoclonal Antibodies Market by Value
3.4.6 Global Infectious Diseases Monoclonal Antibodies Market Forecast by Value
3.5 Global Monoclonal Antibodies Market Value by End-Users
3.5.1 Global Hospital Monoclonal Antibodies Market by Value
3.5.2 Global Hospital Monoclonal Antibodies Market Forecast by Value
3.5.3 Global Research Institutes Monoclonal Antibodies Market by Value
3.5.4 Global Research Institutes Monoclonal Antibodies Market Forecast by Value
3.6 Global Monoclonal Antibodies Capacity and Demand Volume
3.7 Global Monoclonal Antibodies Market Value by Region

Continue…

Inquire More About This Report: https://www.researchmoz.us/enquiry.php?type=E&repid=2735798

For More Information Kindly Contact:
ResearchMoz
Mr. Rohit Bhisey,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Media Release: https://www.researchmoz.us/pressrelease
Follow me on : http://marketresearchlatestreports.blogspot.com/